UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000020055
Receipt No. R000022510
Scientific Title Tests of cytomegalovirus fetomaternal infection
Date of disclosure of the study information 2015/12/03
Last modified on 2021/06/11 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Tests of cytomegalovirus fetomaternal infection
Acronym Tests of cytomegalovirus fetomaternal infection
Scientific Title Tests of cytomegalovirus fetomaternal infection
Scientific Title:Acronym Tests of cytomegalovirus fetomaternal infection
Region
Japan

Condition
Condition Cytomegalovirus fetomaternal infection
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We perform cytomegalovirus antibody test, viral nucleic acid test, and viral isolation test of infected mothers and congenitally infected babies.
Basic objectives2 Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Duration of cytomegalovus(CMV)IgM, low IgG avidity, CMV nucleic acid, and CMV isolation
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria infected mother with consent
Key exclusion criteria congenitally infected baby from infected mother with mother's consent
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Tomoaki
Middle name
Last name Ikeda
Organization Mie University Graduate School of Medicine
Division name Department of Obstetrics and Gynecology
Zip code 514-8507
Address 2-174 Edobashi, Tsu, Mie
TEL 059-232-1111
Email t-kuniaki@clin.medic.mie-u.ac.jp

Public contact
Name of contact person
1st name Kuniaki
Middle name
Last name Toriyabe
Organization Mie University Graduate School of Medicine
Division name Department of Obstetrics and Gynecology
Zip code 514-8507
Address 2-174 Edobashi, Tsu, Mie
TEL 059-232-1111
Homepage URL
Email to.kuniaki@gmail.com

Sponsor
Institute Mie University
Institute
Department

Funding Source
Organization Mie University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization the Clinical Research Ethics Review Committee of the Mie University Hospital
Address 2-174 Edobashi, Tsu, Mie
Tel 059-232-1111
Email kk-sien@mo.medic.mie-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 三重大学医学部附属病院

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 03 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 12 Month 03 Day
Date of IRB
2015 Year 12 Month 01 Day
Anticipated trial start date
2015 Year 12 Month 03 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Study design:cohort study
Recruitment plan:patients matching for the criteria from December 2015
Measurement items:Cytomegalovirus(CMV)IgM, IgG avidity, CMV DNA, and CMV isolation

Management information
Registered date
2015 Year 12 Month 03 Day
Last modified on
2021 Year 06 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022510